Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahel Frick

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Plos One|March 25, 2021
Robustification of RosettaAntibody and Rosetta SnugDockJeliazko R Jeliazkov, Rahel Frick, Jing Zhou, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Targeting the MHC Ligandome by Use of TCR-Like AntibodiesLene Støkken Høydahl, Rahel Frick, Inger Sandlie, et al.
Frontiers in Immunology|November 7, 2022
Hallucinating structure-conditioned antibody libraries for target-specific bindersSai Pooja Mahajan, Jeffrey A Ruffolo, Rahel Frick, et al.
Proteomics|August 29, 2015
Consolidation of proteomics data in the Cancer Proteomics databaseMagnus Ø Arntzen, Paul Boddie, Rahel Frick, et al.
Proteins|September 16, 2022
De novo design and Rosetta-based assessment of high-affinity antibody variable regions (Fv) against the SARS-CoV-2 spike receptor binding domain (RBD)Veda Sheersh Boorla, Ratul Chowdhury, Ranjani Ramasubramanian, et al.
European Journal of Immunology|October 4, 2019
A TRAV26-1-encoded recognition motif focuses the biased T cell response in celiac diseaseRahel Frick, Kristin Støen Gunnarsen, Shiva Dahal-Koirala, et al.
Proteins|September 22, 2025
Docking With Rosetta and Deep Learning Approaches in CAPRI Rounds 47-55Ameya Harmalkar, Lee-Shin Chu, Samuel W Canner, et al.
Protein Engineering, Design & Selection : PEDS|July 24, 2022
Affinity maturation of TCR-like antibodies using phage display guided by structural modelingRahel Frick, Lene S Høydahl, Ina Hodnebrug, et al.
Nature Protocols|January 27, 2017
Modeling and docking of antibody structures with RosettaBrian D Weitzner, Jeliazko R Jeliazkov, Sergey Lyskov, et al.
Communications Biology|August 18, 2022
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-lifeTorleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Plos One|March 25, 2021
Robustification of RosettaAntibody and Rosetta SnugDockJeliazko R Jeliazkov, Rahel Frick, Jing Zhou, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Targeting the MHC Ligandome by Use of TCR-Like AntibodiesLene Støkken Høydahl, Rahel Frick, Inger Sandlie, et al.
Frontiers in Immunology|November 7, 2022
Hallucinating structure-conditioned antibody libraries for target-specific bindersSai Pooja Mahajan, Jeffrey A Ruffolo, Rahel Frick, et al.
Proteomics|August 29, 2015
Consolidation of proteomics data in the Cancer Proteomics databaseMagnus Ø Arntzen, Paul Boddie, Rahel Frick, et al.
Proteins|September 16, 2022
De novo design and Rosetta-based assessment of high-affinity antibody variable regions (Fv) against the SARS-CoV-2 spike receptor binding domain (RBD)Veda Sheersh Boorla, Ratul Chowdhury, Ranjani Ramasubramanian, et al.
European Journal of Immunology|October 4, 2019
A TRAV26-1-encoded recognition motif focuses the biased T cell response in celiac diseaseRahel Frick, Kristin Støen Gunnarsen, Shiva Dahal-Koirala, et al.
Proteins|September 22, 2025
Docking With Rosetta and Deep Learning Approaches in CAPRI Rounds 47-55Ameya Harmalkar, Lee-Shin Chu, Samuel W Canner, et al.
Protein Engineering, Design & Selection : PEDS|July 24, 2022
Affinity maturation of TCR-like antibodies using phage display guided by structural modelingRahel Frick, Lene S Høydahl, Ina Hodnebrug, et al.
Nature Protocols|January 27, 2017
Modeling and docking of antibody structures with RosettaBrian D Weitzner, Jeliazko R Jeliazkov, Sergey Lyskov, et al.
Communications Biology|August 18, 2022
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-lifeTorleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, et al.
Pageof 2